Back to search

Massachusetts Institute of Technology

Controlled release microneedle technologies for the enhanced immunogenicity of subunit vaccines

Abstract

dc:description.abstract

The poor efficacy of subunit protein vaccines, which typically consist of a protein antigen and a molecular adjuvant, has recently been improved by completing multiple injections of the vaccine with an exponential dosing profile over time. The hypothesis is that as viruses replicate in a host organism, they shed exponentially increasing quantities of pathogen associated molecular patterns (PAMPs) and viral protein, and replicating this pattern during vaccination allows scientists to better mimic the immune response elicited by an actual infection. Instead of completing multiple injections, a promising alternative is to complete a one-time application of a microneedle device to the skin that controllably releases the vaccine to mimic this exponential pattern to manipulate the immune system into providing strong humoral and cellular mediated protection. A number of different novel microneedle constructs have been created in this thesis towards this end. Membrane microneedles consist of tips with a polymeric core that contains vaccine that's encapsulated within a crosslinked layer-by-layer film. The three component film acts as a tunable diffusional barrier to vaccine release. Poly([gamma]-propargyl 1-glutamate) (PPLG) polymer grafted with maleimides was used to make microneedles that function based on the same concept except that the tip's surfaces are chemically crosslinked with poly(ethylene glycol) dithiol to enable controlled release. Importantly, degradable ester bonds are incorporated into the network to allow for tunability. Finally, poly(vinyl alcohol) microneedles were vapor-phase crosslinked to form reversible acetal bonds, and these constructs were also characterized and shown to allow for controlled release. Several other constructs were also generated. The work presented herein involves the microneedle design, fabrication, and characterization of these constructs with various experimental set-ups and techniques.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Department of Chemical Engineering
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zmolek, Andrew Charles
Advisor dc:contributor.advisor
  • Paula T. Hammond and Darrell J. Irvine.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/115019
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/115019

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Zmolek, Andrew Charles. Controlled release microneedle technologies for the enhanced immunogenicity of subunit vaccines. Massachusetts Institute of Technology, 2017. http://hdl.handle.net/1721.1/115019